Top Story

Combined surgical diagnostic tools improve gross total resection, not survival, in glioma

May 21, 2015

Intraoperative MRI and 5-aminolevulinic acid were not predictors of improved survival in patients with glioma when used together, according to data from a Swiss study.

However, the use of both tools increases the likelihood of gross total resection during surgery, which may augment survival rates, results showed.

Stephen R. Rapp, PhD In the Journals

Donepezil displays some cognitive benefit for patients with irradiated brain tumors

May 13, 2015
Donepezil was not associated with significant improvements in cognitive functioning among survivors of brain tumors who underwent irradiation, according to the results…
In the JournalsPerspective

Some long-term survivors of low-grade glioma experience decline in health-related quality of life

May 7, 2015
Some long-term survivors of low-grade glioma may experience a significant decline in physical role function and general health perceptions despite having stable disease…
FDA News

FDA grants orphan drug designation to Reolysin for malignant gliomas

April 17, 2015
The FDA today granted orphan drug designation to pelareorep for the treatment of patients with malignant gliomas, according to a press release from the drug’s…
CME CNE
Low Risk AAMDS

Treatment Decision-Making through the Spectrum of MDS:
Case 1 Low Risk MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain MDS…
More »
CME CNE
Stem Cell Transplant for AAMDS

Treatment Decision-Making through the Spectrum of MDS:
Case 3 Stem Cell Transplant for MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain to…
More »
In the Journals

Combined surgical diagnostic tools improve gross total resection, not survival, in glioma

May 21, 2015
Intraoperative MRI and 5-aminolevulinic acid were not predictors of improved survival in patients with glioma when used together, according to data…
Stephen R. Rapp, PhD In the Journals

Donepezil displays some cognitive benefit for patients with irradiated brain tumors

May 13, 2015
Donepezil was not associated with significant improvements in cognitive functioning among survivors of brain tumors who underwent irradiation…
In the JournalsPerspective

Some long-term survivors of low-grade glioma experience decline in health-related quality of life

May 7, 2015
Some long-term survivors of low-grade glioma may experience a significant decline in physical role function and general health perceptions despite…
FDA News

FDA grants orphan drug designation to Reolysin for malignant gliomas

April 17, 2015
The FDA today granted orphan drug designation to pelareorep for the treatment of patients with malignant gliomas, according to a press release from…
Sunit Das, MD, PhD In the Journals

Hypofractionated radiation, temozolomide effective in elderly patients with glioblastoma

April 17, 2015
Hypofractionated radiotherapy or temozolomide monotherapy may be a viable treatment option for elderly patients with glioblastoma multiforme…
FDA News

FDA grants orphan drug status to pritumumab for brain cancer

April 10, 2015
The FDA has granted orphan drug designation to pritumumab for the treatment of brain cancer, according to a press release from the drug’s…
Industry News

VB-111 plus bevacizumab confers positive interim results in recurrent glioblastoma

March 26, 2015
Interim results from an ongoing phase 2 study demonstrated that patients with recurrent glioblastoma who received VB-111 alone and subsequently with…
In the Journals

Metronomic temozolomide extends PFS, OS in EGFR-amplified glioblastoma

March 16, 2015
Patients with epidermal growth factor receptor-amplified and -overexpressing glioblastomas demonstrated a significant benefit from metronomic…
Richard Pazdur, MD FDA News

FDA approves Unituxin for pediatric patients with high-risk neuroblastoma

March 10, 2015
The FDA today announced the approval of dinutuximab for the treatment of pediatric patients with high-risk neuroblastoma, according to a press…
Breaking News

Oraya receives CE mark extension for IRay to treat choroidal metastases

March 3, 2015
The Oraya IRay radiotherapy system received a CE mark extension for the treatment of choroidal metastases, expanding on prior approval for treatment…
More Headlines »
morganatic-roan